Table 1. Correlation between the patients’ clinicopathological factors and level of peripheral blood monocyte count.
| Variable | N | Peripheral blood monocytes (/µL) | P value | |
|---|---|---|---|---|
| Low (<590, n=40) | High (≥590, n=30) | |||
| Gender | 0.010 | |||
| Male | 26 | 20 (50.0%) | 6 (20.0%) | |
| Female | 44 | 20 (50.0%) | 24 (80.0%) | |
| Age | 0.836 | |||
| <60 | 36 | 21 (52.5%) | 15 (50.0%) | |
| ≥60 | 34 | 19 (47.5%) | 15 (50.0%) | |
| CA199 | 0.598 | |||
| Normal | 21 | 11 (27.5%) | 10 (33.3%) | |
| Elevated | 49 | 29 (72.5%) | 20 (66.7%) | |
| CEA | 0.659 | |||
| Normal | 47 | 26 (65.0%) | 21 (70.0%) | |
| Elevated | 23 | 14 (35.0%) | 9 (30.0%) | |
| Grade | 0.382 | |||
| 1 | 23 | 15 (37.5%) | 8 (26.7%) | |
| 2 | 25 | 15 (37.5%) | 10 (33.3%) | |
| 3 | 22 | 10 (25.0%) | 12 (40.0%) | |
| T stage | 0.131 | |||
| T1/2 | 13 | 5 (12.5%) | 8 (26.7%) | |
| T3/4 | 57 | 35 (87.5%) | 22 (73.3%) | |
| Tumor size | 0.457 | |||
| <3 cm | 22 | 14 (35.0%) | 8 (26.7%) | |
| ≥3 cm | 48 | 26 (65.0%) | 22 (73.3%) | |
| Lymphnodes status | 0.008 | |||
| Negative | 29 | 22 (55.0%) | 7 (23.3%) | |
| Positive | 41 | 18 (45.0%) | 23 (76.7%) | |
| Distant metastasis | 0.583 | |||
| Negative | 58 | 34 (85.0%) | 24 (80.0%) | |
| Positive | 12 | 6 (15.0%) | 6 (20.0%) | |
CEA, carcinoembryonic antigen.